$30.35
+0.02 (+0.07%)
DAN News8 articles
Eaton Outperforms S&P 500, Trades at 40x Earnings
Eaton shares rose 2.2% for the week, outperforming the S&P 500. The stock trades at 39.8 times trailing earnings, with a focus on margins and upcoming economic data.
Eaton Shares Tumble 7.6% as $13.2B in Value Vanishes Amid Premium Valuation Concerns
Eaton shares plunged 7.6% in five sessions, erasing $13.2 billion in value, as the stock trades at 30x 2026 earnings. Heavy volume signals investor caution ahead of Q2 results.
Danaher's 50% Rebound Faces $100M Bioprocessing Deferral Hurdle
Danaher shares rebounded 50% from a post-earnings drop, but a $100 million bioprocessing revenue delay to 2027 tests the recovery.
Danaher Plunges 11% as Biotech Growth Disappoints, Triggering Valuation Reset
Danaher shares dropped 11% after its biotech segment underperformed expectations, leading to a valuation adjustment. Full-year core growth guidance was narrowed to 3%-4%.
Danaher Tumbles 11% as Biotech Growth Disappoints, Triggering Valuation Reset
Danaher shares plunged 11% on Tuesday after biotech growth fell short of expectations, prompting a sharp valuation reset even as quarterly revenue and earnings topped forecasts.
Danaher Shares Plunge 14% on Reduced Growth Forecast and Bioprocessing Gap
Danaher (DHR) stock dropped 14% after the company slashed its 2026 core-revenue growth forecast to 3%-4%, citing a bioprocessing order-to-revenue gap that overshadowed a quarterly earnings beat.
Danaher Shares Extend Decline Ahead of Key Fed, Economic Data
Danaher shares dropped 1.1% Friday, continuing a two-session decline. Trading volume was active as markets prepare for a holiday closure and a data-heavy week ahead.
Danaher Shares Slip Ahead of Holiday, Traders Eye PCE Data
Danaher shares fell in extended trading Friday, closing near $212.58. The dip precedes a market holiday, with attention shifting to next week's key inflation report.